MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
equity, net of issuance...
$105,065K
Proceeds from exercise of
warrants
$2,289K
Proceeds from issuance of
equity, net of issuance...
$912K
Proceeds from exercise of
stock options and...
$139K
Proceeds from maturities
of marketable...
$45,743K
Proceeds from sales of
marketable securities
$10,958K
Net cash provided by
financing activities
$108,405K
Net cash provided by
investing activities
$56,083K
Canceled cashflow
$618K
Net change in cash,
cash equivalents and...
$96,224K
Canceled cashflow
$68,264K
Stock-based compensation
$13,046K
Depreciation and
amortization
$8,436K
Non-cash operating lease
expense
$2,473K
Other noncurrent
assets
-$571K
Prepaid expenses and
other current assets
-$547K
Accrued and other
current liabilities
$532K
Other
-$423K
Amortization (accretion) of
premium (discount) on...
$411K
Other noncurrent
liabilities
$102K
Purchases of property and
equipment
$618K
Net cash used in
operating activities
-$68,264K
Canceled cashflow
$26,541K
Net loss
-$90,597K
Operating lease
liabilities
-$2,778K
Accounts payable
-$1,430K
Back
Back
Cash Flow
source: myfinsight.com
Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc. (TNYA)